In response to the needs of domestic academic research institutions and biotechnology companies, our Biosafety Level 2 (BSL-2) laboratory of ID Core is responsible for the development of required assays and performs studies of emerging infectious diseases. We provide the research collaboration, commissioned research and/or technical service for both academia and biotechnology industries, targeting on pre-clinical cell-based efficacy examination, virulence, pathogenesis studies, as well as immunological bridging analyses.
🎯 Research positioning
- Focus on the research and technical services of Risk Group 2 (RG2) agents
- Focus on critical infectious diseases that affect public health, including but not only on the following pathogens:
- Seasonal influenza, such as Influenza A (H1N1, H3N2), Influenza B viruses
- Common cold human coronavirus (hCoV), such as OC43, NL63.
- Respiratory syncytial virus (RSV)
- Enterovirus
- Dengue virus
- Other ONE Health (Human-Animal-Environment) associated common zoonotic or human pathogens
🧪 Scope of services
- Provide collaborative/commissioned research and technical services to support domestic academia, research institutions, and the biotech industry product development
- Perform the diagnostics and cell-based anti-RG2 agents assays, sucth as ELISA, Rapid test, disinfectant functional tests.
- Support preclinical testing and efficacy evaluation of new drugs, antibodies, and vaccines, such as neutralization test, HI assay…etc.
- Conduct validation analysis of reagents and products related to the prevention and control of infectious diseases.
🚀 Accelerating domestic bioindustry development
- Conduct the commissioned research/services, to accelerate the translation of outstanding biomedical research findings into viable products, and to support the development of domestic biotechnology industry.
🛡️ Epidemic prevention role
- In response to domestic or global epidemics/pandemic, we will also be part of national epidemic prevention system, and endeavored to provide strong technical supports on prevention and control of infectious diseases
Team
The Infectious Disease Core facility (ID Core) has experienced microbiology and immunology research team that is responsible for the management and conduct of experimental studies of infectious research in the BSL-2 laboratories. We provide collaborative/commissioned research and technical services of infectious disease.
Commissioned research/service items (ID Core BSL-2 laboratory):
- Development and testing of microbial diagnostic reagents
- Drug screening and efficacy test
- Research and development of the vaccines of emerging infectious diseases, and immune response analyses (correlates of protection):
- Blood CBC and blood biochemical analysis
- Cellular immunity (T cells)
- Humoral immunity (B cells)
- Multiplex Cytokine/Chemokine analysis
- Development of disinfectant and efficacy evaluation
- Efficacy evaluation of bio-protective equipment
- Customized collaborative or commissioned services targeting on the development of vaccines, drugs, or device testing
BSL-2 lab rental
(1) Applicant qualifications: All domestic and foreign academic research/industry team
(2) Rental period: one week to one year
Contact us
Facility Director: Dr. Jeff Liao, Tel: 886-2-7750-5813
Email: jfliao@as.edu.tw
• BSL-2 lab rental
Contact: Miss Mandy Chu, Tel: 886-2-7750-5500 #2577
Email:as0191687@as.edu.tw
Contact information for website correction: Ms. Wu Tel: (02) 7750-5500#2579
E-mail:kiswu2003@as.edu.tw
